Your browser doesn't support javascript.
loading
IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.
Maifrede, Silvia; Martin, Kayla; Podszywalow-Bartnicka, Paulina; Sullivan-Reed, Katherine; Langer, Samantha K; Nejati, Reza; Dasgupta, Yashodhara; Hulse, Michael; Gritsyuk, Daniel; Nieborowska-Skorska, Margaret; Lupey-Green, Lena N; Zhao, Huaqing; Piwocka, Katarzyna; Wasik, Mariusz A; Tempera, Italo; Skorski, Tomasz.
Affiliation
  • Maifrede S; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Martin K; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Podszywalow-Bartnicka P; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Sullivan-Reed K; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Warsaw, Poland.
  • Langer SK; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Nejati R; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Dasgupta Y; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hulse M; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Gritsyuk D; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Nieborowska-Skorska M; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Lupey-Green LN; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Zhao H; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Piwocka K; Temple University Lewis Katz School of Medicine, Department of Clinical Sciences, Philadelphia, Pennsylvania.
  • Wasik MA; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Warsaw, Poland.
  • Tempera I; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Skorski T; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania. tskorski@temple.edu tempera@temple.edu.
Mol Cancer Res ; 15(8): 967-972, 2017 08.
Article in En | MEDLINE | ID: mdl-28634224
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma / BRCA2 Protein / DNA Breaks, Double-Stranded / Poly (ADP-Ribose) Polymerase-1 Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma / BRCA2 Protein / DNA Breaks, Double-Stranded / Poly (ADP-Ribose) Polymerase-1 Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article